Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis through histone acetylation and upregulation of annexin A1 in AML1-ETO expressing kasumi-1 cells.

被引：0
|
作者：
Tabe, Y
Contractor, R
Radke, S
Andreeff, M
Konopleva, M
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Houston, TX USA
[2] Juntendo Univ Med, Tokyo, Japan
[3] Mt Sinai Sch Med, New York, NY USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4343
引用
收藏
页码：170B / 170B
页数：1
相关论文
共 50 条
  • [1] Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells
    Zhuang, Jianjian
    Xia, Liping
    Zou, Zheyu
    Yin, Juxin
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [2] Blue light induces ROS mediated apoptosis and degradation of AML1-ETO oncoprotein in Kasumi-1 cells
    Jianjian Zhuang
    Liping Xia
    Zheyu Zou
    Juxin Yin
    Medical Oncology, 2022, 39
  • [3] Upregulation of MDR1 and induction of doxorubicin resistance by synergistic use of histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells.
    Tabe, Y
    Konopleva, M
    Contractor, R
    Igari, J
    Andreeff, M
    BLOOD, 2003, 102 (11) : 860A - 860A
  • [4] Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing TF-1 cells.
    Tauchi, T
    Nakajima, A
    Sashida, G
    Sumi, M
    Gotoh, A
    Broxmeyer, HE
    Ohyashiki, JH
    Ohyashiki, K
    BLOOD, 2005, 106 (11) : 291B - 291B
  • [5] Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide
    Mizutani, Hideki
    Hiraku, Yusuke
    Tada-Oikawa, Saeko
    Murata, Mariko
    Ikemura, Kenji
    Iwamoto, Takuya
    Kagawa, Yoshiyuki
    Okuda, Masahiro
    Kawanishi, Shosuke
    CANCER SCIENCE, 2010, 101 (10) : 2214 - 2219
  • [6] Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib
    Sutheesophon, K
    Kobayashi, Y
    Takatoku, MA
    Ozawa, K
    Kano, Y
    Ishii, H
    Furukawa, Y
    ACTA HAEMATOLOGICA, 2006, 115 (1-2) : 78 - 90
  • [7] Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of bax, which is enhanced by proteasome inhibitor bortezomib.
    Sutheesophon, K
    Kobayashi, Y
    Takatoku, MA
    Ozawa, K
    Kano, Y
    Ishii, H
    Furukawa, Y
    BLOOD, 2005, 106 (11) : 192B - 192B
  • [8] Combination of histone deacetylase inhibitor depsipeptide (FK228) and ATRA enhances differentiation in ATRA-sensitive and -resistant APL cells.
    Tabe, Y
    Contractor, R
    Konopleva, M
    Igari, J
    Andreeff, M
    BLOOD, 2003, 102 (11) : 258B - 258B
  • [9] Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells
    Hoshino, I
    Matsubara, H
    Hanari, N
    Mori, M
    Nishimori, T
    Yoneyama, Y
    Akutsu, Y
    Sakata, H
    Matsushita, K
    Seki, N
    Ochiai, T
    CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7945 - 7952
  • [10] Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
    Hiroki Sawa
    Hiromi Murakami
    Masaoki Kumagai
    Matsuyoshi Nakasato
    Shigeru Yamauchi
    Nozomu Matsuyama
    Yasuo Tamura
    Akira Satone
    Wataru Ide
    Ikuo Hashimoto
    Hajime Kamada
    Acta Neuropathologica, 2004, 107 : 523 - 531
12345